Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Biosyent Inc BIOYF


Primary Symbol: V.RX

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (TSXV:RX)

VANC Pharmaceuticals could earn 75% net margin with OTC iron supplement

The Life Sciences Report March 29, 2016

Most oil storage in at least 80 years?

Stockhouse Editorial April 1, 2015

Bullboard Posts (TSXV:RX)

A disciplined quarter from Rene & Co | Stock should be $16

I think the record sales with broader based growth from all lines was very encouraging.  The slight decline in profitability is...
FormerHedgie - 1 day ago

Why not acquire co.s like this?

https://www.newswire.ca/news-releases/duchesnay-pharmaceutical-group-celebrates-expansion-of-its-treatment-portfolio-for-nausea-and...
lscfa - October 10, 2024

The acquisition of Tibelia is strategically important

I was quite happy to see the announcement of Tibelia by RX.  While there wasn't nearly enough financial information to determine...
FormerHedgie - September 23, 2024

RE:New Press Release - BioSyent Announces Agreement to Purchase Tibelia&#xAE; (tibolone) Assets

<< View Post To Watch Video >>
lscfa - September 20, 2024

RE:BioSyent Declares Third Quarter 2024 Dividend

Love bio.my pension fund just keeps growing.love it
northernman59 - August 30, 2024

RE:RE:Record qtr sales

Co's that hold a conference call to discuss earnings results must preannounce it to alert shareholders. RX does not hold CC's so...
lscfa - August 27, 2024